BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Airsupra (albuterol / budesonide) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Airsupra (albuterol / budesonide)\, from 
 ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06422689-3562@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20270203
DTEND;VALUE=DATE:20270204
SUMMARY:Airsupra (albuterol / budesonide): Phase 4 readout est. (NCT0642268
 9)
DESCRIPTION:Airsupra (albuterol / budesonide)\, phase 4\, Asthma.\nStudy: C
 ombination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue T
 herapy on Health Outcomes in Routine Care\nEstimated primary completion: 3
  February 2027. This is a ClinicalTrials.gov estimate\, not a confirmed re
 adout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/albut
 erol-budesonide#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT06422689
URL:https://assetmemo.bio/drug/albuterol-budesonide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07166939-3562@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20270630
DTEND;VALUE=DATE:20270701
SUMMARY:Airsupra (albuterol / budesonide): Phase 4 readout est. (NCT0716693
 9)
DESCRIPTION:Airsupra (albuterol / budesonide)\, phase 4\, Asthma.\nStudy: 4
 5th Multicenter Airway Research Collaboration\nEstimated primary completio
 n: June 2027. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/albuter
 ol-budesonide#upcoming-events\nRegistry record: https://clinicaltrials.gov
 /study/NCT07166939
URL:https://assetmemo.bio/drug/albuterol-budesonide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06473779-3562@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20270625
DTEND;VALUE=DATE:20270626
SUMMARY:Airsupra (albuterol / budesonide): Phase 3 readout est. (NCT0647377
 9)
DESCRIPTION:Airsupra (albuterol / budesonide)\, phase 3\, Asthma.\nStudy: O
 pen-label Study to Assess Reduction of Background Asthma Medication While 
 Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patie
 nts 12-80yrs With Severe Asthma.\nEstimated primary completion: 25 June 20
 27. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/albuterol-budeson
 ide#upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT
 06473779
URL:https://assetmemo.bio/drug/albuterol-budesonide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06471257-3562@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20271004
DTEND;VALUE=DATE:20271005
SUMMARY:Airsupra (albuterol / budesonide): Phase 3 readout est. (NCT0647125
 7)
DESCRIPTION:Airsupra (albuterol / budesonide)\, phase 3\, Asthma.\nStudy: A
  Study to Investigate Efficacy and Safety of PT027 Compared With PT007 in 
 Symptomatic Chinese Adults With Asthma\nEstimated primary completion: 4 Oc
 tober 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readou
 t date\, and it can move.\nDrug page: https://assetmemo.bio/drug/albuterol
 -budesonide#upcoming-events\nRegistry record: https://clinicaltrials.gov/s
 tudy/NCT06471257
URL:https://assetmemo.bio/drug/albuterol-budesonide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06307665-3562@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20271013
DTEND;VALUE=DATE:20271014
SUMMARY:Airsupra (albuterol / budesonide): Phase 3 readout est. (NCT0630766
 5)
DESCRIPTION:Airsupra (albuterol / budesonide)\, phase 3\, Asthma.\nStudy: E
 valuating the Efficacy and Safety of PT027 Compared With PT007 Administere
 d As Needed in Participants 12 to < 18 Years of Age With Asthma\nEstimated
  primary completion: 13 October 2027. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/albuterol-budesonide#upcoming-events\nRegistry record: ht
 tps://clinicaltrials.gov/study/NCT06307665
URL:https://assetmemo.bio/drug/albuterol-budesonide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
